Stress Management in Patients With Coronary Artery Disease

NCT ID: NCT04223882

Last Updated: 2023-06-29

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

90 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-10-05

Study Completion Date

2023-10-05

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Introduction: Stress can cause hemodynamic and metabolic changes that contribute to endothelial dysfunction and there is a significant association between high stress and cardiovascular events. Objective: To evaluate the influence of stress management on endothelial function in patients undergoing percutaneous coronary intervention (PCI). Methods: Randomized, controlled, parallel, intention-to-treat clinical trial. Will be considered eligible patients who underwent percutaneous coronary intervention and who have high stress (above average for the Brazilian population) in the Perceived Stress Scale (PSS-10). Patients will be evaluated on PCI admission and stress management with cognitive behavioral techniques will be implemented one month after hospital discharge in the intervention group. Group sessions will be held between 6-9 people. There will be 4 1-hour meetings for 8 weeks. The primary outcome will be the difference in the variation of brachial artery flow-mediated dilatation (FMD) between the groups and at 3 months of baseline evaluation and at 6-month follow-up after the intervention and the secondary outcome will be the difference in the variation of the velocity of brachial artery. Pulse wave evaluated at the same time periods as DMF. Outcomes will be evaluated by Generalized Estimation Equations (GEE). Expected Results: In patients undergoing high-stress percutaneous coronary intervention, the use of cognitive behavioral techniques for stress management will improve endothelial function and vascular stiffness.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Stress, Psychological

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Group Intervention- Management of stress

Patients in the intervention group will receive usual medical care and more stress management intervention. Stress management with cognitive behavioral techniques will be implemented one month after hospital discharge in the intervention group. Group sessions will be held between 6-9 people. There will be 3 1-hour meetings for 3 weeks. The intervention will be performed by psychologist.

Group Type EXPERIMENTAL

Management of Stress

Intervention Type BEHAVIORAL

Psychoeducation:

Coronary artery disease, Percutaneous Coronary Intervention, traditional risk factors and emotional stress.

Stress: physiology, triggers, triad (thinking, emotion, action).

Skills training:

Identify warning signs - signs and symptoms; Monitoring of irrational automatic thoughts generating alternative interpretations of situations or unrealistic thinking patterns (Dysfunctional Thinking Records Sheet).

Self-control for stress management:

Assertiveness training, problem solving. Thought-stopping technique, designed for dysfunctional thoughts, such as, "I won't do it," "It won't work."

Stress Relief / Control Techniques:

Diaphragmatic Breathing: Expansion of the abdomen rather than the chest when breathing.

Progressive Muscle Relaxation: Maximize tension and alternately relax the muscles (legs, abdomen, chest, arms and face).

Group Control

Patients in the control group will receive usual medical care.

Group Type ACTIVE_COMPARATOR

Usual care

Intervention Type OTHER

outpatient medical appointments

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Management of Stress

Psychoeducation:

Coronary artery disease, Percutaneous Coronary Intervention, traditional risk factors and emotional stress.

Stress: physiology, triggers, triad (thinking, emotion, action).

Skills training:

Identify warning signs - signs and symptoms; Monitoring of irrational automatic thoughts generating alternative interpretations of situations or unrealistic thinking patterns (Dysfunctional Thinking Records Sheet).

Self-control for stress management:

Assertiveness training, problem solving. Thought-stopping technique, designed for dysfunctional thoughts, such as, "I won't do it," "It won't work."

Stress Relief / Control Techniques:

Diaphragmatic Breathing: Expansion of the abdomen rather than the chest when breathing.

Progressive Muscle Relaxation: Maximize tension and alternately relax the muscles (legs, abdomen, chest, arms and face).

Intervention Type BEHAVIORAL

Usual care

outpatient medical appointments

Intervention Type OTHER

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Patients in the control group will receive usual medical care

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age ≥ 18 years;
* Patients with CAD - obstruction of one or more epicardial arteries with at least 70% stenosis and / or Left Coronary Trunk (TBI) with at least 50% - measured by catheterization (CATE) and having performed elective PCI
* High stress: above average score for the Brazilian population in the Perceived Stress Scale (PSS-10)
* Signing of the Informed Consent.

Exclusion Criteria

* Age ≥ 80 years
* Patients with inpatient events (AMI, CABG, stroke)
* Indication of catheterization for valvulopathies or congenital heart disease
* Severe aortic stenosis / Ejection fraction \<30%, cardiomyopathy, severe congestive heart disease
* Severe diseases with life expectancy \<6 months
* Cognitive or mental difficulties to understand the instrument
* Inability to follow up visits
Minimum Eligible Age

18 Years

Maximum Eligible Age

79 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Instituto de Cardiologia do Rio Grande do Sul

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Marcia Moura Schmidt, PhD

Role: STUDY_DIRECTOR

Instituto de Cardiologia do Rio Grande do Sul

Karine Elisa Schwarzer Schmidt

Role: PRINCIPAL_INVESTIGATOR

Instituto de Cardiologia do Rio Grande do Sul

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Marcia Moura Schmidt

Porto Alegre, Rio Grande do Sul, Brazil

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Brazil

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

UP 5648/19

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Strategies for Responding to Stress
NCT03289156 COMPLETED NA